Fundamental and Translational Insights into Colorectal Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 September 2025 | Viewed by 46
Special Issue Editor
Interests: histopathology; neuropathology; histological diagnosis; brain tumors; surgical pathology
Special Issue Information
Dear colleague,
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, driven by genetic, epigenetic, and environmental factors. Fundamental research has identified key molecular pathways involved in CRC, including mutations in APC, KRAS, and TP53, as well as the role of the Wnt/β-catenin signaling pathway. Emerging insights into the tumor microenvironment, immune response, and gut microbiota have further expanded our understanding of CRC progression.
Translational research is bridging the gap between these discoveries and clinical applications, leading to advancements in early detection, targeted therapies, and immunotherapy. Liquid biopsy and circulating tumor DNA analysis are improving non-invasive diagnostics. Novel treatments, such as immune checkpoint inhibitors and personalized medicine approaches, are showing promise in improving patient outcomes.
Despite these advancements, challenges remain, including drug resistance and tumor heterogeneity. The continued integration of fundamental and translational research is essential for developing innovative therapies and improving survival rates in patients with CRC.
Dr. Giuseppe Broggi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer (CRC)
- molecular pathways
- translational research
- immune checkpoint inhibitors
- drug resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
